Biosynthetic And structural studies of a heavy chain disease protein

di Ein, Daniel, Buell, Donald N., Fahey, John L.
Pubblicazione 1969

SEPARATION OF HUMAN LYMPHOID CELLS INTO G(1), S, AND G(2) CELL CYCLE POPULATIONS BY USE OF A VELOCITY SEDIMENTATION TECHNIQUE

di Everson, Lloyd K., Buell, Donald N., Rogentine, G. Nicholas
Pubblicazione 1973

Insulin-Dependent Regulation of Insulin Receptor Concentrations: A Direct Demonstration in Cell Culture

di Gavin, James R., Roth, Jesse, Neville, David M., De Meyts, Pierre, Buell, Donald N.
Pubblicazione 1974

Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

di Bekersky, Ihor, Fielding, Robert M., Dressler, Dawna E., Lee, Jean W., Buell, Donald N., Walsh, Thomas J.
Pubblicazione 2002

Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amp...

di Bekersky, Ihor, Fielding, Robert M., Dressler, Dawna E., Lee, Jean W., Buell, Donald N., Walsh, Thomas J.
Pubblicazione 2002

Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected with Aspergillus Species and Other Filamentous Fungi: Maximum Tolerat...

di Walsh, Thomas J., Goodman, Jesse L., Pappas, Peter, Bekersky, Ihor, Buell, Donald N., Roden, Maureen, Barrett, John, Anaissie, Elias J.
Pubblicazione 2001

Population Pharmacokinetics of Micafungin in Neonates and Young Infants

di Hope, William W., Smith, P. Brian, Arrieta, Antonio, Buell, Donald N., Roy, Michael, Kaibara, Atsunori, Walsh, Thomas J., Cohen-Wolkowiez, Michael, Benjamin, Daniel K.
Pubblicazione 2010

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

di Andes, David, Ambrose, Paul G., Hammel, Jeffrey P., Van Wart, Scott A., Iyer, Varsha, Reynolds, Daniel K., Buell, Donald N., Kovanda, Laura L., Bhavnani, Sujata M.
Pubblicazione 2011

Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

di Seibel, Nita L., Schwartz, Cindy, Arrieta, Antonio, Flynn, Patricia, Shad, Aziza, Albano, Edith, Keirns, James, Lau, Wendi M., Facklam, David P., Buell, Donald N., Walsh, Thomas J.
Pubblicazione 2005

Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates

di Smith, P Brian, Walsh, Thomas J, Hope, William, Arrieta, Antonio, Takada, Akitsugu, Kovanda, Laura L, Kearns, Gregory L, Kaufman, David, Sawamoto, T, Buell, Donald N, Benjamin, Daniel K
Pubblicazione 2009

Population Pharmacokinetics of Micafungin in Pediatric Patients and Implications for Antifungal Dosing

di Hope, William W., Seibel, Nita L., Schwartz, Cindy L., Arrieta, Antonio, Flynn, Patricia, Shad, Aziza, Albano, Edythe, Keirns, James J., Buell, Donald N., Gumbo, Tawanda, Drusano, George L., Walsh, Thomas J.
Pubblicazione 2007

Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants

di Benjamin, Daniel K, Smith, P Brian, Arrieta, Antonio, Castro, Lisa, Sánchez, Pablo J, Kaufman, David, Arnold, Leah J, Kovanda, Laura L, Sawamoto, Taiji, Buell, Donald N, Hope, William W, Walsh, Thomas J
Pubblicazione 2009

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis()

di Denning, David W., Marr, Kieren A., Lau, Wendi M., Facklam, David P., Ratanatharathorn, Voravit, Becker, Cornelia, Ullmann, Andrew J., Seibel, Nita L., Flynn, Patricia M., van Burik, Jo-Anne H., Buell, Donald N., Patterson, Thomas F.
Pubblicato in J Infect (2006)